%FSNBUPMPHZ 

.BOBHJOH
QTPSJBTJT
JO
UIF
FMEFSMZ

7HILEPSORIASISREMAINSINCURABLE'0SCANˆBYPRESCRIBINGAPPROPRIATETOPICAL
TREATMENTSANDJUDICIOUSLYREFERRINGˆMARKEDLYIMPROVEOUTCOMES.EVERTHELESSAS
$R2ICHARD0ARSLEWEXPLAINS'0SNEEDTOCONSIDERSEVERALISSUESWHENMANAGINGPSORIASIS
INTHEELDERLYINCLUDINGTHOSEOFPRIMARYCAUSESEMOTIONALANDPHYSICALCONSEQUENCES
ANDCLINICALTREATMENTS

!
ROUNDMILLIONPEOPLEINTHE5+ 5BCMF
5ZQFT
PG
QTPSJBTJT
BOE
UIFJS


SUFFERFROMPSORIASISANDWITHTHE
DMJOJDBM
GFBUVSFT  
AGEINGOFTHEPOPULATIONITISBECOMING
INCREASINGLYWIDESPREADAMONGTHEMIDDLE AGED 5ZQF
PG
QTPSJBTJT $MJOJDBM
GFBUVSFT
ANDELDERLY!NYONEOFTHESEVERALTYPESOF
PSORIASISSEE4ABLE CANUNDERMINEHEALTH 1MBRVFUZQF 4ZNNFUSJD
CJMBUFSBM
UIJDL

SFE
MFTJPOT
XJUI
TJMWFSZ

RELATEDQUALITYOFLIFE(21O, ATANYAGE TDBMF
BDDPVOUT
GPS

QFS

(OWEVERTHEPSYCHOLOGICALBURDENAND(21O, DFOU
PG
DBTFT

%3
3*$)"3%
1"34-&8
JT
B
DPOTVMUBOU
EFSNBUPMPHJTU
BU
UIF

IMPACTMAYBEEVENGREATERAMONGTHEELDERLY
(VUUBUF 5FBSESPQTIBQFE
QJOL
UP

TBMNPO
TDBMZ
QMBRVFT

VTVBMMZ
PDDVST
PO
UIF

#FOFBUI
UIF
TVSGBDF USVOL
MFTT
DPNNPO
PO

QBMNT
BOE
TPMFT
7HILETHEPRIMARYCAUSEREMAINSUNKNOWNTHE
CONSENSUSAMONGRESEARCHERSSUGGESTSTHAT
PSORIASISARISESFROMTHEINTERACTIONOFMULTIPLE 1VTUVMBS
MPDBMJTFE &SZUIFNBUPVT
QBQVMFT
PS

QMBRVFT
TUVEEFE
XJUI

GENESIMMUNEDYSFUNCTIONANDENVIRONMENTAL QVTUVMFT
6TVBMMZ
PDDVST

FACTORS3EVERALLINESOFEVIDENCESUPPORTTHIS PO
QBMNT
PS
TPMFT

QBMNPQMBOUBS
QVTUVMBS

MODEL&OREXAMPLE QTPSJBTJT

ABOUTPERCENTOFPATIENTSHAVEA
lRST DEGREERELATIVEWHOSUFFERSFROMTHE 1VTUVMBS
HFOFSBMJTFE 4BNF
BT
MPDBMJTFE
CVU

DISEASEANDPSORIASISSEEMSMORECOMMON XJEFS
JOWPMWFNFOU
NBZ

#SPBEHSFFO
)PTQJUBM
-JWFSQPPM

CF
BTTPDJBUFE
XJUI

AMONG#AUCASIANSTHANINOTHERETHNIC TZTUFNJD
TZNQUPNT

GROUPSBOTHOFWHICHIMPLICATEGENETIC GFWFS
NBMBJTF
BOE

EJBSSIPFB

TPNF
QBUJFOUT

FACTORS EP
OPU
IBWF
QSFFYJTUJOH

NUMEROUSENVIRONMENTALFACTORSTRIGGEROR QTPSJBTJT
EXACERBATEPSORIASISINCLUDINGSTRESS
&SZUISPEFSNJD 4FWFSF
JOUFOTF

INFECTIONSTRAUMA+OEBNERPHENOMENON  HFOFSBMJTFE
FSZUIFNB

ANDCERTAINMEDICATIONSINCLUDINGSOME BOE
TDBMJOH
DPWFST
CPEZ

PGUFO
BTTPDJBUFE
XJUI

WIDELYUSEDBYELDERLYPEOPLESUCHASBETA TZTUFNJD
TZNQUPNT

BLOCKERS.3!)$SAND!#%INHIBITORS  TPNF
QBUJFOUT
EP
OPU

IBWF
QSFFYJTUJOH

0SORIASISSEEMSTOARISEWHENANENVIRONMENTAL QTPSJBTJT
FACTORINTERACTSWITHTHEINHERITEDPREDISPOSITIONTO

KBOVBSZ
  NJEMJGF
BOE
CFZPOE 
HFSJBUSJD
NFEJDJOF

  %FSNBUPMPHZ

ACTIVATEHELPER4HELPER4H LYMPHOCYTES4HE ELDERLYPEOPLEMAYBEATHIGHERRISKOFMORTALITY

4HCELLSRELEASECYTOKINESTHATSTIMULATE DUETOCO
MORBIDITIESORADVERSEEVENTS0SORIASIS
KERATINOCYTEPROLIFERATIONANDINCREASEEXPRESSION ISFOREXAMPLEASSOCIATEDWITHANINCREASEDRISKOF
OFADHESIONMOLECULESINBLOODVESSELSSUPPLYING NON
MELANOMASKINCANCERANDLYMPHOMA
THESKIN)NTURNTHEADHESIONMOLECULESAUGMENT ESPECIALLYINPATIENTSWITHMORESEVEREDISEASE)TIS
CYTOKINEPRODUCTIONBY4HLYMPHOCYTESFURTHER UNCLEARHOWEVERWHETHERTHISASSOCIATIONARISES
PROMOTINGKERATINOCYTEPROLIFERATIONAND FROMTHEDISEASEASIDEEFFECTORBOTH
INCREASINGEPIDERMALTURNOVER
/THERCOMPLICATIONSINCLUDEPSORIATICARTHRITIS
4HISIMMUNOLOGICALCYCLEMEANSCHRONICPLAQUE WHICHTENDSTOBEASYMMETRICANDAFFECTSlNGERS
PSORIASISBEGINSASPAPULESWHICHCOALESCEINTOWELL
ANDTOES"ETWEENlVEPERCENTANDSEVENPERCENT
DEMARCATEDPLAQUES4HELESIONSBLEEDIFTHESILVERY OFPEOPLEWITHPSORIASISDEVELOPPSORIATICARTHRITIS
SCALEISREMOVED!USPITZSIGN ANDOVERPERCENT ALTHOUGHTHEPREVALENCEREACHESAROUND
OFPATIENTSREPORTITCHWHICHSEEMSTOHAVEA PERCENTINPATIENTSWITHEXTENSIVEDISEASE
COMPLEXAETIOLOGYINCLUDINGINCREASEDLEVELSOF $EPRESSIONANXIETYANDSEXUALPROBLEMSAREALSO
MASTCELLSSUBSTANCE0ANDNERVEGROWTHFACTOR COMMON)NDEEDSOMEPATIENTSWITHPSORIASIS
.'& %LBOWSANDKNEESARETHEMOSTCOMMON SHOWSUICIDALIDEATION(OWEVERTHEASSOCIATION
SITESAFFECTEDALTHOUGHMANYPATIENTSDEVELOP WITHSEVERITYISNOTLINEARˆPSYCHOLOGICAL
LESIONSONTHEIRLOWERBACKSCALPORNAILS/LDER PROBLEMSMAYEMERGEAMONGPEOPLEWITH
PATIENTSANDOTHERSWITHALONGDURATIONOFDISEASE OBJECTIVELYLESSSEVEREDISEASE
THOSEWITHEXTENSIVEINVOLVEMENTORPSORIATIC
ARTHRITIS AREESPECIALLYPRONETODEVELOPNAIL !STHESEEXAMPLESOFTHEPSYCHOLOGICALBURDEN
PSORIASIS7HILERARELYTHEPRESENTINGSYMPTOMNAIL SUGGESTPSORIASISCANMARKEDLYUNDERMINE
PSORIASISMAYBECONFUSEDWITHONYCHOMYCOSIS (21O,)NDEEDTHEIMPACTISSIMILARTOOTHER
ANOTHERDISEASECOMMONINTHEELDERLY CHRONICDISEASESEXPERIENCEDBYTHEELDERLYSUCHAS
DEPRESSIONMYOCARDIALINFARCTIONHYPERTENSION
CONGESTIVEHEARTFAILUREORTYPEDIABETES
"
DPNNPO
DPOEJUJPO $ESPITETHEDECLINEINPREVALENCETHEREISNO
"ETWEENPERCENTANDTWOPERCENTOFTHE5+ EVIDENCETHATTHEIMPACTON(21O,LESSENSWITH
POPULATIONSUFFERSFROMPSORIASIS-ENANDWOMEN ADVANCINGAGE)NAPOSTHOCANALYSISASSESSING
SEEMTOBEEQUALLYLIKELYTODEVELOPTHECONDITION ETANERCEPTNOSTATISTICALLYSIGNIlCANTDIFFERENCES
4HEAGEOFONSETPEAKSTWICEONCEINTHELATETEENS EMERGEDINTHE$ERMATOLOGY,IFE1UALITY)NDEX
ANDAGAININTHELATES4HEPREVALENCEDECLINES $,1) SCORESBETWEENELDERLYANDYOUNG
BYPERCENTANDPERCENTBETWEENnYEARS PATIENTS)NDEEDPSORIASISMAYIMPOSEAGREATER
ANDnYEARSRESPECTIVELYCOMPAREDWITHn BURDENONELDERLYPEOPLEACCORDINGTOASTUDYOF
YEARS4HEPREVALENCETHENFALLSTOPERIN
PATIENTSYEARSOROVER!RECENTANALYSIS
REPORTEDTHATPERCENTOF5+PSORIASISPATIENTS
WEREMORETHANYEARSOLD4HEDECLINEMAY

PATIENTSHOSPITALISEDWITHTHECONDITION
0ATIENTSAGEDYEARSOROLDERREPORTEDAGREATER
IMPAIRMENTINTHEIR(21O,THANTHOSELESSTHAN
YEARSOFAGEONALLDOMAINSOFTHE3KINDEX
SUGGESTPSORIASISGOESINTOREMISSIONTHATELDERLY SCALE4HISSCALEISARELIABLEANDVALIDSELF
PATIENTSMAYBELESSLIKELYTHANYOUNGERPEOPLETO ADMINISTEREDINSTRUMENTDESIGNEDFORMEASURING
BRINGTHECONDITIONTOTHEIRDOCTORSATTENTIONOR HEALTHRELATEDQUALITYOFLIFEINDERMATOLOGY)T
BOTH)NARECENTSTUDYPERCENTOFPATIENTSSAID CONSISTSOFITEMSLOADINGONTHREESCALESTO
THEYHADNOTCONSULTEDTHEIRDOCTORABOUTTHEIR MEASURETHEEFFECTSOFSKINCONDITIONSON
PSORIASISINTHEPRECEDINGYEAR3EVERALFACTORS SYMPTOMSEMOTIONALSTATEANDSOCIALFUNCTIONING
COULDCONTRIBUTETOTHISLOWCONSULTATIONRATE 4HEQUESTIONSREFERTOTHEPREVIOUSFOURWEEK
INCLUDINGDECREASINGCONCERNSABOUTPHYSICAL PERIODANDSCORESAREGIVENONAlVE
POINTSCALE
APPEARANCEPOORPREVIOUSEXPERIENCESWITH FROM@NEVERTO@ALLTIMEHIGH(IGHERSCORES
TREATMENTSANDLOWEXPECTATIONOFSUCCESS INDICATEPOORERQUALITYOFLIFE &URTHERMOREOLDER
PATIENTSENDUREDGREATERPSYCHOLOGICALDISTRESS
/LDERWOMENSUFFERINGFROMCONCURRENTANXIETY
&NPUJPOBM
BOE
QIZTJDBM
ANDDEPRESSIONSHOWEDTHEWORST(21O,
DPOTFRVFODFT
0SORIASISISNOTCOMMONLYFATAL%RYTHRODERMIC 7HILETHEPOTENTIALLYPROFOUNDIMPACTOF
PSORIASISCANBEFATALBUTTHISISRARE.EVERTHELESS PSORIASISON(21O,ISWELLESTABLISHEDFEWSTUDIES

HFSJBUSJD
NFEJDJOF  NJEMJGF
BOE
CFZPOE 
KBOVBSZ


 %FSNBUPMPHZ 

EXAMINEWHETHERTHISCHANGESOVERTIME(OWEVER PATIENTS#ORTICOSTEROIDCOMBINATIONSANDTOPICAL
ONERECENTSTUDYEXAMINED(21O,DURINGAN VITAMIN$ANALOGUESWEREEACHUSEDBYAROUND
 YEARFOLLOW UPUSINGTHE)MPACTOF0SORIASIS PERCENTOFPATIENTSRESPECTIVELY*USTONEIN
1UESTIONNAIRE)03/ 4HEIMPACTONMOSTSOCIAL PATIENTSUSEDASYSTEMICAGENT4HEWIDESPREAD
DETERMINANTSOF(21O,REMAINEDSTABLE)N USEOFSTEROIDSISTESTAMENTTOTHEIREFlCACYAND
CONTRASTCONCERNSABOUTPHYSICALAPPEARANCE TOLERABILITYALTHOUGHSIDEEFFECTSMAYINCLUDESKIN
DECREASEDANDMEAN)03/SCORESDECLINEDBYA ATROPHYSTRIAEANDTACHYPHYLAXISIFTHEYAREUSED
lFTH&URTHERMORETHEPROPORTIONOFPATIENTSIN INAPPROPRIATELY#ONCERNSABOUTSIDEEFFECTSMAY
WHOMPSORIASISSEEMSTOHAVEALOWOVERALLIMPACT LEADSOMEPATIENTSANDPHYSICIANSUNDERDOSING
ON(21O,INCREASEDFROMPERCENTATBASELINE WITHTOPICALSTEROIDS(OWEVERASTHEREISMORE
TOPERCENTAFTERYEARS4HEIMPROVEMENTWAS UNDERSTANDINGASTOTHEIRNATURETOPICALSTEROIDS
ESPECIALLYMARKEDINPATIENTSREPORTINGPOOR ARENOWAVAILABLEINAVARIETYOFPOTENCIES
HEALTHWHERETHEMEANINCREASEWASAROUNDTHREE STRENGTHSANDFORMULATIONS4HISALLOWSCLINICIANS
TIMESGREATERTHANAMONGTHOSEINGOODHEALTH TOTAILORTREATMENTACCORDINGTOTHEPATIENTAS
4HESESTUDIESSUGGESTTHATWHILESOMEPATIENTS WELLASDIFFERENCESINTHESENSITIVITYANDTHICKNESS
ADAPTTOSUFFERINGFROMTHEIRDISEASEPSORIASIS OFTHESKIN
UNDERMINESPSYCHOLOGICALWELL BEINGAND(21O,
ATALLAGES 6ITAMIN$DERIVATIVESEGCALCIPOTRIOL
NORMALISEKERATINOCYTEPROLIFERATIONAND
0SORIASISIMPOSESAHEAVYECONOMICBURDEN DIFFERENTIATION#ALCIPOTRIOLISASEFFECTIVEASPOTENT
3IXTYPERCENTOF5+PATIENTSWITHSEVEREPSORIASIS TOPICALSTEROIDSBUTMAYCAUSEPRURITUSORBURNING
TOOKTIMEOFFWORKINTHEPREVIOUSYEARBECAUSEOF (YPERCALCAEMIAISUNLIKELYWHENUSEDACCORDING
THEIRCONDITION&URTHERMOREPEOPLEWITHSEVERE TOTHELABEL-OSTREPORTSOFHYPERCALCAEMIA
DISEASEMAYREQUIREONEORMOREHOSPITALISATIONS OCCURREDINPATIENTSWHORECEIVEDPROLONGED
EACHYEAR%ACHSTAYLASTSFORANAVERAGEOFDAYS TREATMENTWITHGORMOREWEEKLY4HEMAIN
ANDINPATIENTCARECOSTSEXCLUDINGDRUGSTOTAL SIDEEFFECTISIRRITATIONAROUNDTHELESIONALTHOUGH
AROUNDaFOREACHPERSON$URING FEWPATIENTSCEASETREATMENTASARESULT!GAINST
DOCTORSWROTENEARLYONEMILLIONPRESCRIPTIONSFOR THISBACKGROUNDCOMBINATIONTHERAPYOFFERS
PSORIASISTHERAPIESWHICHCOSTaM4HIS SEVERALBENElTS
EXCLUDESTREATMENTSUSEDFOROTHERCONDITIONSEG USEDASACOMBINATIONTHERAPYSTEROIDSAND
CORTICOSTEROIDSORMETHOTREXATE ASWELLASCOSTS CALCIPOTRIOLAREMOREEFFECTIVETHANEITHERAGENT
ARISINGFROMSECONDARYANDTERTIARYCAREANDSO USEDALONE
MARKEDLYUNDERESTIMATESTHECOST#LEARLY STEROIDLESSENSTHEIRRITATIONASSOCIATEDWITH
OPTIMISINGOUTCOMESISIMPORTANTTOLIMITTHE CALCIPOTRIOL
ECONOMICBURDEN STEROIDSACTRAPIDLYCALCIPOTRIOLMAYTAKEUP
TOSIXTOEIGHTWEEKSFORFULLEFFECTSTOEMERGE
APPLYINGTOPICALTREATMENTSMAYBEMESSYAND
1SJNBSZ
DBSF
NBOBHFNFOU TIMECONSUMINGWHICHMAYCOMPROMISE
#LINICIANSNEEDTOCOUNSELPATIENTSTHATPSORIASISIS COMPLIANCEUSINGONEFORMULATIONRATHERTHAN
INCURABLEANDENSURESUFFERERSFOCUSON TWOOBVIOUSLYREDUCESTHETIMEANDMESS
IMPROVEMENTSRATHERTHANCLEARANCE!SONLY
BETWEENPERCENTANDPERCENTOFPATIENTS 3EVERALFORMULATIONSAREAVAILABLEINCLUDING
HAVEMODERATETHREETOPERCENTOFBODY CALCIPOTRIOLPLUSBETAMETHASONEDIPROPIONATE
SURFACEAREA TOSEVEREPSORIASISPERCENT  WHICHANANALYSISOF5+PRESCRIBINGHABITSFOUND
TOPICALAGENTSARETHElRST LINETREATMENT'0S ACCOUNTEDFORPERCENTANDPERCENTOF
SHOULDALSOENCOURAGEPATIENTSTOUSEEMOLLIENTS PSORIASISSCRIPSRESPECTIVELY#ALCIPOTRIOLPLUS
(OWEVERPATIENTSSHOULDAVOIDEMOLLIENTSAND BETAMETHASONEISAONCEDAILYTREATMENTAND
OTHERPRODUCTSCONTAININGLACTICACIDORALPHA CANBEUSEDFORUPTOFOURWEEKSREPEATCOURSES
HYDROXYACIDWHICHMAYIRRITATEINmAMEDOR CANTHENBEPRESCRIBEDIFDEEMEDSUITABLEBYTHE
BROKENSKIN HEALTHCAREPROFESSIONAL)FADEQUATEDOSESOF
CALCIPOTRIOLANDSTEROIDSUSEDINCOMBINATION
.UMEROUSSTUDIESSHOWTOPICALSTEROIDS FAILTOPRODUCEANADEQUATERESPONSEPATIENTS
INCLUDINGBETAMETHASONEMOMETASONEAND MAYBENElTFROMATRIALOFONEORMORE
CLOBETASOL IMPROVEPSORIASIS)NDEEDDOCTORS TOPICALTHERAPIES
ISSUEDSTEROIDSTOAROUNDPERCENTOF5+ TOPICALRETINOIDSEGTAZAROTENE NORMALISES

KBOVBSZ
  NJEMJGF
BOE
CFZPOE 
HFSJBUSJD
NFEJDJOF

  %FSNBUPMPHZ

,FZ
QPJOUT 3FGFSFODFT

t 5IF
DPOTFOTVT
BNPOH
SFTFBSDIFST
TVHHFTUT

(JMMBSE
4&
'JOMBZ
":
$VSSFOU
.PSPIBTIJ
.
1SVSJUPHFOJD

QTPSJBTJT
BSJTFT
GSPN
UIF
JOUFSBDUJPO
PG
NBOBHFNFOU
PG
QTPSJBTJT
JO
UIF
NFEJBUPST
JO
QTPSJBTJT
WVMHBSJT

6OJUFE
,JOHEPN
QBUUFSOT
PG
DPNQBSBUJWF
FWBMVBUJPO
PG
JUDI
NVMUJQMF
HFOFT

JNNVOF
EZTGVODUJPO
BOE

QSFTDSJCJOH
BOE
SFTPVSDF
VTF
JO
BTTPDJBUFE
DVUBOFPVT
GBDUPST
#S

FOWJSPONFOUBM
GBDUPST QSJNBSZ
DBSF
*OU
+
$MJO
1SBDU +
%FSNBUPM
+
%FSNBUPM
 
 
&MFXTLJ
#&
0OZDIPNZDPTJT

t &MEFSMZ
QBUJFOUT
NBZ
CF
MFTT
MJLFMZ
UIBO

4BNQPHOB
'

$ISFO
..

.FMDIJ
QBUIPHFOFTJT

EJBHOPTJT

BOE

ZPVOHFS
QFPQMF
UP
CSJOH
UIF
DPOEJUJPO
UP
UIFJS
$'

FU
BM
"HF

HFOEFS

RVBMJUZ
PG
NBOBHFNFOU
$MJO
.JDSPCJPM
3FW
EPDUPST
BUUFOUJPO MJGF
BOE
QTZDIPMPHJDBM
EJTUSFTT
JO

QBUJFOUT
IPTQJUBMJ[FE
XJUI

6OBF[F
+

/JKTUFO
5

.VSQIZ
"

FU

QTPSJBTJT
#S
+
%FSNBUPM BM
*NQBDU
PG
QTPSJBTJT
PO
IFBMUI
t 1TPSJBTJT
JT
OPU
B
HFSJBUSJD
EJTFBTF
QFS
TF

 SFMBUFE
RVBMJUZ
PG
MJGF
EFDSFBTFT

/FWFSUIFMFTT

UIJT
DPNNPO
TLJO
EJTFBTF

1BSEBTBOJ
"(

'FMENBO
43


$MBSL
PWFS
UJNF
BO
ZFBS

JNQPTFT
BO
JODSFBTJOHMZ
IFBWZ
CVSEFO
PO
"3
5SFBUNFOU
PG
1TPSJBTJT
"O
QSPTQFDUJWF
TUVEZ
+
*OWFTU

NJEEMFBHFE
BOE
FMEFSMZ
QBUJFOUT "MHPSJUIN#BTFE
"QQSPBDI
GPS
%FSNBUPM
%FSNBUPM
 
1SJNBSZ
$BSF
1IZTJDJBOT
"N

.JMJUFMMP
(

9JB
"

4UFWFOT
43


'BN
1IZTJDJBO
 7BO
7PPSIFFT
"4
&UBOFSDFQU
GPS


(FMGBOE
+.

8FJOTUFJO
3

1PSUFS
UIF
USFBUNFOU
PG
QTPSJBTJT
JO
UIF

4#

FU
BM
1SFWBMFODF
BOE
FMEFSMZ
+
"N
"DBE
%FSNBUPM
KERATINOCYTEPROLIFERATIONANDDIFFERENTIATION USFBUNFOU
PG
QTPSJBTJT
JO
UIF


TAZAROTENEAPPEARSTOBEASEFFECTIVEAS 6OJUFE
,JOHEPN
B
QPQVMBUJPO 
'MBNNJHFS
"

.BJCBDI
)
%SVH

CBTFE
TUVEZ
"SDI
%FSNBUPM EPTBHF
JO
UIF
FMEFSMZ

TOPICALSTEROIDSALTHOUGHTHEREARENODIRECT
 EFSNBUPMPHJDBM
ESVHT
%SVHT

COMPARISONSWITHCALCIPOTRIOLSIDEEFFECTS 
-VCB
,.

4UVMCFSH
%-
$ISPOJD
"HJOH

INCLUDESKINIRRITATIONPRURITUSBURNING QMBRVF
QTPSJBTJT
"N
'BN

(SJGm
UIT
$&

5BZMPS
)

$PMMJOT
4*


STINGINGERYTHEMADESQUAMATIONAND 1IZTJDJBO
 FU
BM
5IF
JNQBDU
PG
QTPSJBTJT


/*$&
&UBOFSDFQU
BOE
FGBMJ[VNBC
HVJEFMJOFT
PO
BQQSPQSJBUFOFTT
PG

TERATOGENICITYADVERSEEFFECTSAPPEARTOBE
GPS
UIF
USFBUNFOU
PG
BEVMUT
XJUI
SFGFSSBM
GSPN
QSJNBSZ
UP

MORECOMMONWITHTAZAROTENETHAN QTPSJBTJT
-POEPO
/BUJPOBM
TFDPOEBSZ
DBSF
B
SBOEPNJ[FE

CALCIPOTRIOL *OTUJUVUF
GPS
)FBMUI
BOE
$MJOJDBM
DPOUSPMMFE
USJBM
#S
+
%FSNBUPM
TOPICALIMMUNOSUPPRESSANTSEGTACROLIMUS &YDFMMFODF

 

/BLBNVSB
.

5PZPEB
.


INHIBIT4
LYMPHOCYTESADVERSEEVENTSINCLUDE
BURNINGSTINGINGPRURITUSINmUENZA
LIKE
SYMPTOMSERYTHEMAACNEANDFOLLICULITISˆ
SOMEREPORTSLINKTOPICALIMMUNOSUPPRESSANTS
TOSKINCANCERANDLYMPHOMAHOWEVERSTUDIES ORGUKHEALTHCAREGUIDELINES SUGGESTTHATPATIENTS
NEEDTOASCERTAINIFTHELINKISCAUSAL SHOULDRECEIVENOMORETHAN056!TREATMENTS
ANTHRALINNORMALISESKERATINOCYTE OVERTHEIRLIFETIME&URTHERMORETHENEEDTOVISITA
PROLIFERATIONSIDEEFFECTSINCLUDESKIN SPECIALISTCENTRETWOORTHREETIMESAWEEKCAN
IRRITATIONERYTHEMASTAININGOFSKINAND IMPOSEASIGNIlCANTTIMEBURDEN%LDERLYPEOPLE
CLOTHINGANDODOUR MAYALSOFACETRANSPORTATIONPROBLEMS
COALTARISKERATOLYTICANTI
INmAMMATORY
ANDANTIPROLIFERATIVESIDEEFFECTSINCLUDE
SKINIRRITATIONFOLLICULITISODOURANDSTAINING 4ZTUFNJD
USFBUNFOUT
OFCLOTHING 4HE"!$GUIDELINESSUGGESTUSINGSYSTEMIC
)THASBEENSUGGESTEDTHATNEITHERCOALTARNOR THERAPIESINTHEFOLLOWINGCIRCUMSTANCES
ANTHRALINISMOREEFlCACIOUSTHANCALCIPOTRIOL  FAILUREOFANADEQUATETRIALOFTOPICALTHERAPY
$ESPITETHESELIMITATIONSAQUARTEROF5+PATIENTS
USECOALTAR
1IPUPUIFSBQZ
0ATIENTSINWHOMTHEPSORIASISINVOLVESMORETHAN
PERCENTOFTHEIRBODYORWHODONOTRESPONDTO 
REPEATEDHOSPITALADMISSIONSFORTOPICAL
THERAPY
EXTENSIVECHRONICPLAQUEPSORIASISINTHE
ELDERLYORINlRM
GENERALISEDPUSTULARORERYTHRODERMIC
PSORIASIS
SEVEREPSORIATICARTHROPATHY
TOPICALTHERAPYMAYBENElTFROM56" )NGENERALTHE"!$GUIDELINESNOTESYSTEMIC
PHOTOTHERAPYAND056!ACOMBINATIONOFTHE THERAPYISAPPROPRIATEWHENMORETHANPERCENT
PHOTOSENSITISERPSORALENAND56! 4OREDUCETHE OFTHEBODYSURFACEAREATHE0SORIASIS!REAAND
RISKOFSKINCANCERTHE"RITISH!SSOCIATIONOF 3EVERITY)NDEX0!3) SCOREISGREATERTHANORTHE
$ERMATOLOGISTS"!$ GUIDELINESHTTPWWWBAD $,1)ISGREATERTHAN.EVERTHELESSSYSTEMIC

HFSJBUSJD
NFEJDJOF  NJEMJGF
BOE
CFZPOE 
KBOVBSZ